author-photo

James W. Wheless

University of Tennessee Health Science Center
Boston Children's Hospital

208

Papers

4823

Citations

Citation Trend

Filter By

Papers (146) Sort By

Journal Conference Others

Use of Real‐World Data and Pharmacometric Modeling in Support of Lacosamide Dosing in Pediatric Patients Under Four Years of Age

2021 The Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
Lack of observed impact of history or concomitant treatment of seasonal allergies or rhinitis on repeated doses of diazepam nasal spray administered per seizure episode in a day, safety, and tolerability: Interim results from a phase 3, open-label, 12-month repeat-dose safety study.

2021 Epilepsy & Behavior
Show All
- Source
- Cite
- Save
Citations (2)
MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects.

2021 Human Genetics
Show All
- Source
- Cite
- Save
Citations (0)
Return to Full Baseline Functionality After Repeated Intermittent Use of Midazolam Nasal Spray in Patients With Seizure Clusters: Post-Hoc Analysis of an Open-Label Extension Trial (1705)

2021 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Long-Term Safety, Efficacy of Add-on Cannabidiol (CBD) for Treatment of Tuberous Sclerosis Complex-Associated Seizures in an Open-Label Extension

2021 Neuropediatrics
Show All
- Source
- Cite
- Save
Citations (0)
A critical evaluation of midazolam nasal spray for the treatment of patients with seizure clusters.

2021 Expert Review of Neurotherapeutics
- James W. Wheless
Show All
- Source
- Cite
- Save
Citations (1)
PND9 Exploring Serious Adverse Events Associated With Hospitalizations in a Long-term, Phase 3, Open-Label, Repeat-Dose, Safety Study of Diazepam Nasal Spray for Patients With Epilepsy

2021 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray

2021 Epilepsy Research
Show All
- Source
- Cite
- Save
Citations (2)
Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) for Treatment of Seizures Associated with Tuberous Sclerosis Complex (TSC) in an Open-Label Extension (OLE) Trial (GWPCARE6) (1127)

2021 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
VNS therapy for medically refractory partial seizures: An update

2021 Brain Stimulation
- James W. Wheless
Show All
- Source
- Cite
- Save
Citations (0)